Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review

Mitsubishi Tanabe Pharma Corp (4508) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Mitsubishi Tanabe Pharma Corp (Mitsubishi Tanabe), a subsidiary of Mitsubishi Chemical Holdings Corp, identifies, develops, manufactures, procures and commercializes ethical drugs and over-the-counter (OTC) pharmaceutical products. The company develops ethical drugs for autoimmune disease, diabetes, kidney diseases, central nervous system (CNS) disorders and others. It also develops vaccines for preventing various infectious diseases. The company markets its products to wholesalers, hospitals, clinics, and drugstores. It has subsidiaries in Asia, Europe and North America. Mitsubishi Tanabe is headquartered in Chuo-ku, Osaka, Japan.

Mitsubishi Tanabe Pharma Corp Key Recent Developments

Apr 26,2019: BioInvent receives €0.75 million milestone under Mitsubishi Tanabe Pharma partnership
Mar 28,2019: The global health innovative technology fund provides grant for joint research into anti-malarial drugs conducted by Mitsubishi Tanabe Pharma and a malaria research institution
Mar 20,2019: Mitsubishi Tanabe Pharma: Aiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative officeAiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative office
Oct 09,2018: Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo announce second public recruitment offering of ""Joinus"", a joint research program to discover new drugs using drug-repositioning compound library
Sep 28,2018: New country manager brings significant business leadership and healthcare expertise to Mitsubishi Tanabe Pharma Canada

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 

Section 1 - About the Company
Mitsubishi Tanabe Pharma Corp - Key Facts
Mitsubishi Tanabe Pharma Corp - Key Employees
Mitsubishi Tanabe Pharma Corp - Key Employee Biographies
Mitsubishi Tanabe Pharma Corp - Major Products and Services
Mitsubishi Tanabe Pharma Corp - History
Mitsubishi Tanabe Pharma Corp - Company Statement
Mitsubishi Tanabe Pharma Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Mitsubishi Tanabe Pharma Corp - Business Description
Product Category: Domestic Ethical Drugs
Performance
Product Category: OTC Products
Performance
Product Category: Others
Performance
Product Category: Overseas Ethical Drugs
Performance
Product Category: Royalty Revenue
Performance
Geographical Segment: Asia
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Japan
Performance
Geographical Segment: North America
Performance
Geographical Segment: Others
Performance
R&D Overview
Mitsubishi Tanabe Pharma Corp - SWOT Analysis
SWOT Analysis - Overview
Mitsubishi Tanabe Pharma Corp - Strengths
Mitsubishi Tanabe Pharma Corp - Weaknesses
Mitsubishi Tanabe Pharma Corp - Opportunities
Mitsubishi Tanabe Pharma Corp - Threats
Mitsubishi Tanabe Pharma Corp - Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Mitsubishi Tanabe Pharma Corp, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 26, 2019: BioInvent receives €0.75 million milestone under Mitsubishi Tanabe Pharma partnership
Mar 20, 2019: Mitsubishi Tanabe Pharma: Aiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative officeAiming to expand our sales and to strengthen our business foundations in the growing ASEAN market Establishment of sales subsidiary in Malaysia and Vietnam representative office
Oct 09, 2018: Astellas, Mitsubishi Tanabe Pharma, and Daiichi Sankyo announce second public recruitment offering of ""Joinus"", a joint research program to discover new drugs using drug-repositioning compound library
Sep 28, 2018: New country manager brings significant business leadership and healthcare expertise to Mitsubishi Tanabe Pharma Canada
Sep 26, 2018: Mitsubishi Tanabe Pharma announce company name changes of our oversea subsidiaries
Sep 18, 2018: Mitsubishi Tanabe Pharma included in the Dow Jones Sustainability Asia Pacific Index
Jul 02, 2018: Mitsubishi Tanabe Pharma and Osaka University co-found the Department of Neuro-Medical Science - Toward the Innovative Drug Discovery for refractory Neurological Diseases
Jul 02, 2018: Mitsubishi Tanabe Pharma and Osaka University co-found the “Department of Neuro-Medical Science”
Jul 02, 2018: Mitsubishi Tanabe Pharma: Open Call for Applicants for investigator-Initiated Clinical Research Funds
May 30, 2018: Daiichi Sankyo Announces Launch of Immune-mediated Inflammatory Diseases Consortium for Drug Development
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
 

List Of Tables

Mitsubishi Tanabe Pharma Corp, Key Facts
Mitsubishi Tanabe Pharma Corp, Key Employees
Mitsubishi Tanabe Pharma Corp, Key Employee Biographies
Mitsubishi Tanabe Pharma Corp, Major Products and Services
Mitsubishi Tanabe Pharma Corp, History
Mitsubishi Tanabe Pharma Corp, Other Locations
Mitsubishi Tanabe Pharma Corp, Subsidiaries
Mitsubishi Tanabe Pharma Corp, Joint Venture
Mitsubishi Tanabe Pharma Corp, Key Competitors
Mitsubishi Tanabe Pharma Corp, Ratios based on current share price
Mitsubishi Tanabe Pharma Corp, Annual Ratios
Mitsubishi Tanabe Pharma Corp, Annual Ratios (Cont...1)
Mitsubishi Tanabe Pharma Corp, Annual Ratios (Cont...2)
Mitsubishi Tanabe Pharma Corp, Interim Ratios
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
Mitsubishi Tanabe Pharma Corp, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
 

List Of Figures

Mitsubishi Tanabe Pharma Corp, Performance Chart (2015 - 2019)
Mitsubishi Tanabe Pharma Corp, Ratio Charts
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
Mitsubishi Tanabe Pharma Corp, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
 

Fill The Form For Sample Request

There is no Reviews available